当前蛋白身份:B3UEZ6 重新检索
本组结构的主要差异维度
突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
5VN3 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b 提交 2017-04-28 Assembly 1 其他组合 异源复合物;蛋白 × 15 PDB 声明:pentadecameric(15) 与蛋白数一致
链 A 516–668(153 aa)
链 B 516–668(153 aa)
链 D 516–668(153 aa)
突变:I559P, T605C 突变:I559P, T605C 突变:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;DDM was added to a final concentration of 0.06 mM prior to vitrification
cryo-EM玻璃化条件 冷冻剂 ETHANE;3 uL of sample applied to a holey carbon grid on glow discharged face and blotted manually on sample side until filter paper detached from grid, followed by immediate plunging
分辨率 3.70 Å
5VN8 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 提交 2017-04-28 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 A 516–668(153 aa)
链 B 516–668(153 aa)
链 C 516–668(153 aa)
突变:I559P, T605C 突变:I559P, T605C 突变:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;DDM was added to a final concentration of 0.06 mM prior to vitrification
cryo-EM玻璃化条件 冷冻剂 ETHANE;3 uL of sample applied to a holey carbon grid on glow discharged face and blotted manually on sample side until filter paper detached from grid, followed by immediate plunging
分辨率 3.60 Å
6CH9 Crystal structure of a natively-glycosylated B41 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 提交 2018-02-22 Assembly 1 其他组合 异源复合物;蛋白 × 18 PDB 声明:octadecameric(18) 与蛋白数一致
链 B 516–668(153 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;5% Tacismate pH 8.0, 15% PEG 3350
分辨率 4.85 Å R-free 0.292
6EDU B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 提交 2018-08-11 Assembly 1 其他组合 异源复合物;蛋白 × 21 PDB 声明:21-meric(21) 与蛋白数一致
链 A 516–668(153 aa)
链 B 516–668(153 aa)
链 C 516–668(153 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.06 Å
6MUF Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom 提交 2018-10-23 Assembly 1 其他组合 异源复合物;蛋白 × 18 PDB 声明:octadecameric(18) 与蛋白数一致
链 B 516–668(153 aa) 片段:gp41
突变:I559P, A605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;298 K;90mM Na Acetate pH5.5 6% PEG8,000 3% PEG400 450mM NaCl
分辨率 2.91 Å R-free 0.297
6MUG Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom 提交 2018-10-23 Assembly 1 其他组合 异源复合物;蛋白 × 18 PDB 声明:octadecameric(18) 与蛋白数一致
链 B 516–668(153 aa) 片段:gp41
突变:I559P, A605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 42 JYS 1-[4-(benzenecarbonyl)piperazin-1-yl]-2-(4-bromo-7-fluoro-1H-indol-3-yl)ethane-1,2-dione × 3 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;298 K;60mM Na Acetate pH5.5 4% PEG8,000 2%PEG400 300mM NaCl
分辨率 2.95 Å R-free 0.289
6OKP B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 提交 2019-04-14 Assembly 1 其他组合 异源复合物;蛋白 × 14 PDB 声明:tetradecameric(14) 与蛋白数一致
链 A 516–668(153 aa) 片段:UNP residues 516-668
链 B 516–668(153 aa) 片段:UNP residues 516-668
链 C 516–668(153 aa) 片段:UNP residues 516-668
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;0 blot force, 3 second blot time, 3 uL sample added to freshly glow-discharged grids
分辨率 3.28 Å
6OPN CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 提交 2019-04-25 Assembly 1 其他组合 异源复合物;蛋白 × 9 PDB 声明:nonameric(9) 与蛋白数一致
链 B 516–668(153 aa)
链 E 516–668(153 aa)
链 H 516–668(153 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 N07 [3'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-3-yl](piperidin-1-yl)methanone × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;Detergent (LMNG) added shortly (<5 minutes) prior to grid freezing using an 8X concentrated stock.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.50 Å
6OPO Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM 提交 2019-04-25 Assembly 1 其他组合 异源复合物;蛋白 × 15 PDB 声明:pentadecameric(15) 与蛋白数一致
链 B 516–668(153 aa)
链 F 516–668(153 aa)
链 M 516–668(153 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 LMT DODECYL-BETA-D-MALTOSIDE × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;DDM added shortly (<5 minutes) prior to freezing.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.50 Å
6OPP Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM 提交 2019-04-25 Assembly 1 其他组合 异源复合物;蛋白 × 15 PDB 声明:pentadecameric(15) 与蛋白数一致
链 B 516–668(153 aa)
链 E 516–668(153 aa)
链 K 516–668(153 aa)
未记录 LMT DODECYL-BETA-D-MALTOSIDE × 3 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;Detergent added shortly (<5 minutes) prior to grid freezing
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.70 Å
6OPQ CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG 提交 2019-04-25 Assembly 1 其他组合 异源复合物;蛋白 × 15 PDB 声明:pentadecameric(15) 与蛋白数一致
链 B 516–668(153 aa)
链 F 516–668(153 aa)
链 G 516–668(153 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;Detergent (LMNG) added shortly (<5 minutes) prior to grid freezing using an 8X concentrated stock.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.80 Å
6U59 HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B 提交 2019-08-27 Assembly 1 其他组合 异源复合物;蛋白 × 12 PDB 声明:dodecameric(12) 与蛋白数一致
链 B 516–668(153 aa)
链 D 516–668(153 aa)
链 I 516–668(153 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;Detergent was added to sample shortly prior to freezing.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.86 Å
6X5B Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 提交 2020-05-25 Assembly 1 其他组合 异源复合物;蛋白 × 15 PDB 声明:pentadecameric(15) 与蛋白数一致
链 B 516–668(153 aa)
链 E 516–668(153 aa)
链 K 516–668(153 aa)
突变:I559P, T605C 突变:I559P, T605C 突变:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 UOV N-(4'-methyl[1,1'-biphenyl]-4-yl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxamide × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;Detergent diluted into sample shortly before application to grid
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.60 Å
6X5C Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 提交 2020-05-25 Assembly 1 其他组合 异源复合物;蛋白 × 9 PDB 声明:nonameric(9) 与蛋白数一致
链 B 516–668(153 aa)
链 F 516–668(153 aa)
链 G 516–668(153 aa)
突变:I559P, T605C 突变:I559P, T605C 突变:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 23 UOV N-(4'-methyl[1,1'-biphenyl]-4-yl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxamide × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;Detergent diluted into sample shortly before application to grid
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.04 Å
8D5C anti-HIV-1 gp120-sCD4 complex antibody CG10 Fab in complex with B41-sCD4 提交 2022-06-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 15 PDB 声明:pentadecameric(15) 与蛋白数一致
链 X 516–668(153 aa)
链 Y 516–668(153 aa)
链 Z 516–668(153 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.90 Å